TrademarkDir
TETRAVARINEX
LIVE

Serial Number

79036245

Owner

GW Research Limited

Filing Date

Nov 20, 2006

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TETRAVARINEX Trademark

Serial Number: 79036245 • Registration: 3423146

TETRAVARINEX is a trademark filed by GW Research Limited on November 20, 2006. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

Trademark Details

Filing Date

November 20, 2006

Registration Date

May 6, 2008

Published for Opposition

February 19, 2008

Cancellation Date

December 12, 2014

Goods & Services

Pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of obesity associated with type II diabetes, namely, non-insulin dependant diabetes; pharmaceutical preparations for the treatment of bulimia; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of cognitive disorders, such as Alzheimer's; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of drug, alcohol or nicotine abuse; pharmaceutical preparations for the treatment of inflammatory disorders

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2025 ADCH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 30, 2023 INNT
NEW REPRESENTATIVE AT IB RECEIVED
Nov 24, 2021 NREP
CHANGE OF OWNER RECEIVED FROM IB
Sep 13, 2018 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Dec 21, 2017 NREP
INTERNATIONAL REGISTRATION RENEWED
Dec 15, 2016 RNWL
TOTAL INVALIDATION PROCESSED BY THE IB
Sep 24, 2015 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 3, 2015 INTS
INVALIDATION PROCESSED
Sep 3, 2015 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 12, 2015 INTR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 19, 2015 ADCH
CANCELLED SECTION 71
Dec 12, 2014 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Aug 7, 2014 NREP
NOTIFICATION PROCESSED BY IB
Jun 13, 2014 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 22, 2012 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Apr 1, 2011 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Aug 26, 2008 FICS
FINAL DISPOSITION PROCESSED
Aug 26, 2008 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2008 FICR
REGISTERED-PRINCIPAL REGISTER
May 6, 2008 R.PR
PUBLISHED FOR OPPOSITION
Feb 19, 2008 PUBO
NOTICE OF PUBLICATION
Jan 30, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 16, 2008 PREV
ASSIGNED TO LIE
Jan 16, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2007 CNSA
ASSIGNED TO EXAMINER
Nov 28, 2007 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2007 TROA
REFUSAL PROCESSED BY IB
May 25, 2007 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 10, 2007 RFCS
REFUSAL PROCESSED BY MPU
May 10, 2007 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 9, 2007 RFCR
NON-FINAL ACTION WRITTEN
May 8, 2007 CNRT
ASSIGNED TO EXAMINER
Apr 27, 2007 DOCK
NEW APPLICATION ENTERED
Apr 27, 2007 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 26, 2007 REPR

Related Trademarks

More from this Owner

EPIFOS

EPIFOS

EPIDYOLEX

EPIDYOLEX

LIVINGWITH

LIVINGWITH

LIVINGWITH

LIVINGWITH

LIVINGWITH

LIVINGWITH

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT